Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BAXTER INTERNATIONAL INCBAX · Entity 1707 | EVP, Chief Operating Officer | March 02, 2022 | March 04, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BAXTER INTERNATIONAL INC
Report date March 02, 2022 · Filed March 04, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $1 par valueSEC Table I · non-derivative | Direct | 76,495 |
Reported balance
After 2022-03-02 transaction · row 1
1 source rowRow 1 · 2022-03-02 · Grant · Acquired 11,891 · Balance 76,495 F1: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $85.23 · Expires 2032-03-02 | Direct | 55,126 |
Reported balance
After 2022-03-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-03-02 · Grant · Acquired 55,126 · Balance 55,126 F2: The options become exercisable in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.
F2: The options become exercisable in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2018 Filed Jan 3, 2018 21:15 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,754 | $0.00 Strike: $37.17 | $0.00 |
DisclosureSEC source: 0001678067-18-000001 · edgar.xml · derivative · entry 13 Accogli Giuseppe · CIK 0001678067 · SVP, President, Global Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 3,754 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Accogli with respect to the stock options granted by Baxter International Inc. ("BII") to Mr. Accogli. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:15 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,877 | $0.00 Strike: $37.17 | $0.00 |
DisclosureSEC source: 0001678067-18-000001 · edgar.xml · derivative · entry 12 Accogli Giuseppe · CIK 0001678067 · SVP, President, Global Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 1,877 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Accogli with respect to the stock options granted by Baxter International Inc. ("BII") to Mr. Accogli. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:15 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,776 | $0.00 Strike: $37.82 | $0.00 |
DisclosureSEC source: 0001678067-18-000001 · edgar.xml · derivative · entry 11 Accogli Giuseppe · CIK 0001678067 · SVP, President, Global Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 2,776 shares Expires 2024-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Accogli with respect to the stock options granted by Baxter International Inc. ("BII") to Mr. Accogli. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:15 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,776 | $0.00 Strike: $37.82 | $0.00 |
DisclosureSEC source: 0001678067-18-000001 · edgar.xml · derivative · entry 10 Accogli Giuseppe · CIK 0001678067 · SVP, President, Global Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 2,776 shares Expires 2024-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Accogli with respect to the stock options granted by Baxter International Inc. ("BII") to Mr. Accogli. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:15 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1 | $0.00 Strike: $37.82 | $0.00 |
DisclosureSEC source: 0001678067-18-000001 · edgar.xml · derivative · entry 9 Accogli Giuseppe · CIK 0001678067 · SVP, President, Global Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 1 shares Expires 2024-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Accogli with respect to the stock options granted by Baxter International Inc. ("BII") to Mr. Accogli. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:15 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,461 | $0.00 Strike: $30.95 | $0.00 |
DisclosureSEC source: 0001678067-18-000001 · edgar.xml · derivative · entry 8 Accogli Giuseppe · CIK 0001678067 · SVP, President, Global Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 2,461 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Accogli with respect to the stock options granted by Baxter International Inc. ("BII") to Mr. Accogli. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:15 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,241 | $0.00 Strike: $28.97 | $0.00 |
DisclosureSEC source: 0001678067-18-000001 · edgar.xml · derivative · entry 7 Accogli Giuseppe · CIK 0001678067 · SVP, President, Global Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 1,241 shares Expires 2022-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Accogli with respect to the stock options granted by Baxter International Inc. ("BII") to Mr. Accogli. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:15 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | SaleCommon Stock, $1 par value | 28,641 | $67.00 | $1,918,947.00 |
DisclosureSEC source: 0001678067-18-000001 · edgar.xml · nonDerivative · entry 6 Accogli Giuseppe · CIK 0001678067 · SVP, President, Global Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,729 Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:15 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionCommon Stock, $1 par value | 10,000 | $37.38 | $373,800.00 |
DisclosureSEC source: 0001678067-18-000001 · edgar.xml · nonDerivative · entry 5 Accogli Giuseppe · CIK 0001678067 · SVP, President, Global Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,370 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Accogli with respect to the stock options granted by Baxter International Inc. ("BII") to Mr. Accogli. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:15 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionCommon Stock, $1 par value | 9,386 | $37.17 | $348,877.62 |
DisclosureSEC source: 0001678067-18-000001 · edgar.xml · nonDerivative · entry 4 Accogli Giuseppe · CIK 0001678067 · SVP, President, Global Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,370 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Accogli with respect to the stock options granted by Baxter International Inc. ("BII") to Mr. Accogli. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:15 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionCommon Stock, $1 par value | 5,553 | $37.82 | $210,014.46 |
DisclosureSEC source: 0001678067-18-000001 · edgar.xml · nonDerivative · entry 3 Accogli Giuseppe · CIK 0001678067 · SVP, President, Global Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Accogli with respect to the stock options granted by Baxter International Inc. ("BII") to Mr. Accogli. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:15 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionCommon Stock, $1 par value | 2,461 | $30.95 | $76,167.95 |
DisclosureSEC source: 0001678067-18-000001 · edgar.xml · nonDerivative · entry 2 Accogli Giuseppe · CIK 0001678067 · SVP, President, Global Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,431 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Accogli with respect to the stock options granted by Baxter International Inc. ("BII") to Mr. Accogli. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:15 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionCommon Stock, $1 par value | 1,241 | $28.97 | $35,951.77 |
DisclosureSEC source: 0001678067-18-000001 · edgar.xml · nonDerivative · entry 1 Accogli Giuseppe · CIK 0001678067 · SVP, President, Global Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,970 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Accogli with respect to the stock options granted by Baxter International Inc. ("BII") to Mr. Accogli. Read SEC document |
| September 01, 2017 Filed Sep 6, 2017 21:41 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001678067-17-000007 · edgar.xml · nonDerivative · entry 1 Accogli Giuseppe · CIK 0001678067 · SVP, President, Global Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,616 F1 · shares: The reporting person received a grant of 25,000 restricted stock units which are scheduled to vest on September 1, 2021, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2015 Incentive Plan. Read SEC document |
| August 17, 2017 Filed Aug 18, 2017 20:08 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,335 | $0.00 Strike: $37.38 | $0.00 |
DisclosureSEC source: 0001678067-17-000006 · edgar.xml · derivative · entry 4 Accogli Giuseppe · CIK 0001678067 · SVP, President, Global Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock, $1 par value · 1,335 shares Expires 2026-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2017 Filed Aug 18, 2017 20:08 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 11,335 | $0.00 Strike: $37.38 | $0.00 |
DisclosureSEC source: 0001678067-17-000006 · edgar.xml · derivative · entry 3 Accogli Giuseppe · CIK 0001678067 · SVP, President, Global Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 11,335 shares Expires 2026-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2017 Filed Aug 18, 2017 20:08 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | SaleCommon Stock, $1 par value | 12,670 | $60.96 | $772,363.20 |
DisclosureSEC source: 0001678067-17-000006 · edgar.xml · nonDerivative · entry 2 Accogli Giuseppe · CIK 0001678067 · SVP, President, Global Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,616 F1 · price: Price reflects weighted average sales price. Range of prices for transactions are $60.95 through $60.98. Full information regarding the number of shares sold at each separate price will be provided by the issuer upon request. Read SEC document |
| August 17, 2017 Filed Aug 18, 2017 20:08 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionCommon Stock, $1 par value | 12,670 | $37.38 | $473,604.60 |
DisclosureSEC source: 0001678067-17-000006 · edgar.xml · nonDerivative · entry 1 Accogli Giuseppe · CIK 0001678067 · SVP, President, Global Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 22:01 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 1,947 | $59.72 | $116,274.84 |
DisclosureSEC source: 0001678067-17-000005 · edgar.xml · nonDerivative · entry 1 Accogli Giuseppe · CIK 0001678067 · SVP, President, Global Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,570 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock granted on June 2, 2014. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 21:11 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 Par Value | 112 | $50.68 | $5,676.16 |
DisclosureSEC source: 0001678067-17-000004 · edgar.xml · nonDerivative · entry 1 Accogli Giuseppe · CIK 0001678067 · CVP, Renal 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,209 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of partial vesting of restricted stock granted on March 4, 2014. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 21:08 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 819 | $50.91 | $41,695.29 |
DisclosureSEC source: 0001678067-17-000003 · edgar.xml · nonDerivative · entry 1 Accogli Giuseppe · CIK 0001678067 · CVP, Renal 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,322 F1 · shares: Represents an aggregate of 523 shares of Baxter International Inc. (the "Company") common stock and 296 shares of Company common stock forfeited by the reporting person to cover the payment of taxes incurred as a result of partial vesting of restricted stock granted on March 3, 2015 and March 3, 2016, respectively. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 21:21 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantStock Option (Right to Buy) · Derivative | 93,583 | $0.00 Strike: $50.77 | $0.00 |
DisclosureSEC source: 0001678067-17-000002 · edgar.xml · derivative · entry 1 Accogli Giuseppe · CIK 0001678067 · CVP, Renal 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,583 Underlying: Common Stock, $1 par value · 93,583 shares Expires 2027-03-02 F1 · derivative.exercise_date: The option becomes exercisable in three equal annual installments beginning on the first anniversary of the date of the grant. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:17 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 1,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001678067-17-000001 · edgar.xml · nonDerivative · entry 4 Accogli Giuseppe · CIK 0001678067 · CVP, Renal 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,996 F4 · kind: Represents shares earned from the performance share unit award granted on March 3, 2016 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on the Baxter's Adjusted Operating Margin (OM) performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2016 to December 31, 2016. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from January 1, 2016 through December 31, 2018). Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:17 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 536 | $49.96 | $26,778.56 |
DisclosureSEC source: 0001678067-17-000001 · edgar.xml · nonDerivative · entry 3 Accogli Giuseppe · CIK 0001678067 · CVP, Renal 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,966 F3 · kind: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of shares earned in 2014, 2015 and 2016 as part of the 2014 PSUs. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:17 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 818 | $0.00 | $0.00 |
DisclosureSEC source: 0001678067-17-000001 · edgar.xml · nonDerivative · entry 2 Accogli Giuseppe · CIK 0001678067 · CVP, Renal 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,502 F2 · kind: Represents shares awarded from the 2014 PSUs. The award provides that fifty percent of the performance share units are earned based on Baxter's Growth in Shareholder Value (GSV) performance over the Three-Year Performance Period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's GSV during the Three-Year Performance Period. These shares have vested as the Three-Year Performance Period has ended. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:17 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 423 | $0.00 | $0.00 |
DisclosureSEC source: 0001678067-17-000001 · edgar.xml · nonDerivative · entry 1 Accogli Giuseppe · CIK 0001678067 · CVP, Renal 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,684 F1 · kind: Represents shares awarded from the performance share unit award granted on March 4, 2014 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2014 PSUs). The award provides that fifty percent of the performance share units are earned based on Baxter's Return on Invested Capital (ROIC) performance, as assessed annually over a three-year period. One-third of the ROIC performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's ROIC during the January 1, 2016 to December 31, 2016 performance period. These shares have vested as the relevant three-year performance period January 1, 2014 to December 31, 2016 (the Three-Year Performance Period) has ended. Read SEC document |
| September 01, 2016 Filed Sep 6, 2016 20:18 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $46.18 | $0.00 |
DisclosureSEC source: 0001678067-16-000003 · edgar.xml · derivative · entry 2 Accogli Giuseppe · CIK 0001678067 · CVP, Renal 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock, $1 par value · 25,000 shares Expires 2026-09-01 F2 · derivative.exercise_date: The option becomes exercisable in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2016 Filed Sep 6, 2016 20:18 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001678067-16-000003 · edgar.xml · nonDerivative · entry 1 Accogli Giuseppe · CIK 0001678067 · CVP, Renal 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,989 F1 · shares: The reporting person received a grant of 5,000 restricted stock units which will vest on September 3, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.